The risk of serotonin syndrome is increased in cases of the concomitant administration with other serotonergic medicines, including tricyclic antidepressants, triptans, fentanyl, tramadol, lithium, buspirone, tryptophan, isocarboxazid, thioridazine, pimozide, intravenous methylene blue, linezolid, amphetamines, phenelzine, procarbazine, selegiline, tranylcypromine and St. John’s Wort